Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Argus Health
Cipla
Deloitte
Chubb
Cerilliant
Federal Trade Commission
Colorcon

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,387,612

« Back to Dashboard

Which drugs does patent 8,387,612 protect, and when does it expire?

Patent 8,387,612 protects ADASUVE and is included in one NDA.

This patent has twenty-one patent family members in six countries.
Summary for Patent: 8,387,612
Title:Self-contained heating unit and drug-supply unit employing same
Abstract: Heating units, drug supply units and drug delivery articles capable of rapid heating are disclosed. Heating units comprising a substrate and a solid fuel capable of undergoing an exothermic metal oxidation reaction disposed within the substrate are disclosed. These heating units can be actuated by electrical resistance, by optical ignition or by percussion. Drug supply units and drug delivery articles wherein a solid fuel is configured to heat a substrate to a temperature sufficient to rapidly thermally vaporize a drug disposed thereon are also disclosed.
Inventor(s): Damani; Ramesh (Sunnyvale, CA), Hale; Ron L. (Sandia Park, NM), Myers; Daniel J. (Mountain View, CA), Quintana; Reynaldo J. (Redwood City, CA), Solas; Dennis W. (San Francisco, CA), Song; Soonho (Hillsborough, CA), Soni; Pravin (Sunnyvale, CA), Tom; Curtis (San Mateo, CA), Sharma; Kirshnamohan (Milpitas, CA)
Assignee: Alexza Pharmaceuticals, Inc. (Mountain View, CA)
Application Number:12/485,704
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,387,612

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,387,612

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,991,387 Self-contained heating unit and drug-supply unit employing same ➤ Sign Up
9,370,629 Self-contained heating unit and drug-supply unit employing same ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,387,612

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2004104490 ➤ Sign Up
Japan 2007516404 ➤ Sign Up
Japan 2007516403 ➤ Sign Up
Japan 2007516149 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Chinese Patent Office
Merck
Dow
Accenture
Moodys
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.